13F Holdings
中文EN

GEHC GE HealthCare Technologies Inc.

X-Ray Apparatus & Tubes & Related Irradiation Apparatus · Nasdaq · SEC CIK 1932393 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY6.9%
TTM net income YoY-2.8%
TTM EPS YoY-2.1%
Revenue 3-yr CAGR3.9%
Net income 3-yr CAGR7.8%

Margins

Gross margin39.9%
Operating margin13.3%
Net margin10.0%
FCF margin8.7%
EBITDA margin14.8%

Returns

ROE19.9%
ROA5.8%
ROIC (approx.)13.2%
Asset turnover0.58x

Leverage & solvency

Liabilities / assets69.1%
Debt / equity0.86x
Current ratio1.30x
Interest coverage6.60x

Cash quality & payout

Operating cash flow / net income1.12x
Accruals ratio-0.7%
Payout ratio3.0%
Capex / revenue2.4%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31FY20232023-12-31FY20222022-12-31FY20212021-12-31
Income statement
Revenue$20.62B$19.67B$19.55B$18.34B$17.59B
Gross profit$8.25B$8.21B$7.92B$7.18B$7.17B
R&D expense$1.26B$1.31B$1.21B$1.03B$816.00M
SG&A expense$4.22B$4.27B$4.28B$3.63B$3.56B
Operating income$2.76B$2.62B$2.44B$2.52B$2.79B
Interest expense$440.00M$504.00M$542.00M$77.00M$40.00M
Pretax income$2.77B$2.58B$2.36B$2.51B$2.88B
Income tax$614.00M$531.00M$743.00M$563.00M$600.00M
Net income$2.08B$1.99B$1.57B$1.92B$2.25B
EBITDA$3.05B$2.89B$2.68B$2.75B$3.02B
EPS (basic)4.564.373.054.224.95
EPS (diluted)4.554.343.034.224.95
Dividends declared per share0.140.120.12——
Weighted avg. shares (diluted)458.00M459.00M458.00M454.00M454.00M
Balance sheet
Cash & equivalents$4.49B$2.89B$2.51B$1.45B$561.00M
Inventory$2.23B$1.94B$1.96B$2.15B—
Current assets$12.50B$9.90B$9.41B$8.32B—
PP&E, net——$2.14B$2.00B—
Goodwill$13.49B$13.14B$12.94B$12.81B$12.89B
Intangibles$1.13B$1.08B$1.25B$1.52B—
Total assets$36.91B$33.09B$32.45B$27.54B—
Current liabilities$9.11B$9.55B$8.98B$7.19B—
Short-term debt$502.00M$1.50B$1.00B$15.00M—
Long-term debt$9.49B$7.45B$8.44B$8.23B—
Total debt$10.00B$8.95B$9.44B$8.25B—
Total liabilities$26.31B$24.44B$25.14B$17.95B—
Shareholders' equity$10.38B$8.45B$7.13B$9.36B$16.68B
Net debt$5.50B$6.06B$6.93B$6.80B—
Shares outstanding——455.34M100—
Cash flow statement
Operating cash flow$1.99B$1.96B$2.10B$2.13B$1.61B
Capital expenditure$482.00M$401.00M$387.00M$310.00M$248.00M
Free cash flow$1.50B$1.55B$1.71B$1.82B$1.36B
Investing cash flow-$1.05B-$914.00M-$558.00M-$398.00M-$1.76B
Financing cash flow$617.00M-$573.00M-$478.00M-$822.00M-$263.00M
Depreciation & amortization$287.00M$268.00M$248.00M$228.00M$225.00M
Stock-based compensation$130.00M$125.00M$114.00M$67.00M$76.00M
Dividends paid$64.00M$55.00M$41.00M$0$0
Share buybacks$200.00M$0$0——

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.